Разработка и регистрация лекарственных средств is a peer-reviewed russian-language open-access journal published by LLC Center of Pharmaceutical Analytics (LLC «CPHA») in Russian Federation, operating under an open-access model since 2016. The journal covers Industries. Land use. Labor: Special industries and trades: Pharmaceutical industry.
Authors publish in Разработка и регистрация лекарственных средств without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY license (see other journals using this license).
To date, Разработка и регистрация лекарственных средств has published 656 articles. Articles are minted with DOIs through the prefix 10.33380.
Keywords
acute toxicity, antimicrobial activity, bioavailability, bioequivalence, clinical trials, drugs
At a glance
- Country
- Russian Federation
- Primary language
- Russian
- License
- CC BY
- Peer review
- Double anonymous peer review
- OA since
- 2016
- DOI prefix
10.33380
ISSN
- 2305-2066
- electronic
- 2658-5049
Frequently asked questions
Is Разработка и регистрация лекарственных средств peer-reviewed?
Does Разработка и регистрация лекарственных средств charge an article processing charge (APC)?
What subjects does Разработка и регистрация лекарственных средств publish?
What languages does Разработка и регистрация лекарственных средств accept?
What is the ISSN of Разработка и регистрация лекарственных средств?
2305-2066 (print) · 2658-5049 (electronic).